Two Perth-based resources companies are planning to switch sectors with the acquisition of cancer-based biotechnology firms, with one planning a backdoor listing and the other seeking support for an IPO.
Two Perth-based resources companies are planning to switch sectors with the acquisition of cancer-based biotechnology firms, with one planning a backdoor listing and the other seeking support for an IPO.